Literature DB >> 8201639

Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease.

S Stewart1, M Malto, L Sandberg, K K Colburn.   

Abstract

The cause of Peyronie's disease is unknown. Immunological mechanisms in the pathogenesis have been previously suggested. Antibodies to elastin are present in all individuals. However, abnormal serum levels of anti-tropoelastin (reflecting elastin synthesis) and anti-alpha-elastin (reflecting elastin destruction) are seen in a variety of autoimmune diseases. We show that patients with Peyronie's disease have higher levels of antibodies to tropoelastin (p < 0.047) and alpha-elastin (p < 0.012) than age-matched controls, suggesting an increase in elastin synthesis and breakdown, respectively. These findings suggest the presence of autoimmune mechanisms in the pathogenesis of Peyronie's disease, which may have future diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201639     DOI: 10.1016/s0022-5347(17)32828-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix.

Authors:  Alan W Shindel; Guiting Lin; Hongxiu Ning; Lia Banie; Yun-Ching Huang; Gang Liu; Ching-Shwun Lin; Tom F Lue
Journal:  J Sex Med       Date:  2010-03-30       Impact factor: 3.802

2.  Peyronie's Disease: A Review.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Rev Urol       Date:  2003

3.  Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.

Authors:  Romano Gennaro; Davide Barletta; Gianni Paulis
Journal:  Int Urol Nephrol       Date:  2015-08-11       Impact factor: 2.370

4.  US Imaging in Peyronie's Disease.

Authors:  Kiriaki Kalokairinou; Charalampos Konstantinidis; Marilena Domazou; Theodoros Kalogeropoulos; Prodromos Kosmidis; Aristomenis Gekas
Journal:  J Clin Imaging Sci       Date:  2012-10-31

Review 5.  Conservative management options for Peyronie's disease.

Authors:  Gregory S Jack; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

6.  Clinical and epidemiological characteristics of young patients with Peyronie's disease: a retrospective study.

Authors:  Gianni Paulis; Giorgio Cavallini; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2015-07-09

7.  Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification.

Authors:  Ludovic Ferretti; Thomas M Fandel; Xuefeng Qiu; Haiyang Zhang; Hazem Orabi; Alex K Wu; Lia Banie; Guifang Wang; Guiting Lin; Ching-Shwun Lin; Tom F Lue
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

8.  Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.

Authors:  M Alizadeh; F Karimi; M R Fallah
Journal:  Glob J Health Sci       Date:  2014-09-18

Review 9.  Peyronie's disease: advances in basic science and pathophysiology.

Authors:  T J Bivalacqua; S K Purohit; W J Hellstrom
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

Review 10.  The pathophysiology of Peyronie's disease.

Authors:  Ahmed I El-Sakka; Emre Salabas; Murat Dinçer; Ates Kadioglu
Journal:  Arab J Urol       Date:  2013-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.